MICRUS ENDOVASCULAR (NASDAQ:MEND)
13.13
0.43 (3.17%)
| MICRUS ENDOVASCULAR (NASDAQ:MEND) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $13.56 | 52 Week High | $13.85 | ||
| Open | $13.19 | 52 Week Low | $4.13 | ||
| Day High | $13.33 | P/E | 52.52 | ||
| Day Low | $13.09 | EPS | $0.25 | ||
| Volume | 30,723 | ||||
| More MEND Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| CTCM | 3 | PCS | 2 |
| MBRK | 2 | CVS | 2 |
| ABK | 2 | HURN | 2 |
| INOD | 2 | RSOL | 2 |
| DGIT | 2 | ANSS | 2 |
| KSWS | 2 | GKK | 2 |
Entities who have mentioned MEND
- Robert W Baird | View Related Stories »
- Citi | View Related Stories »
- KeyBanc | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Needham & Co | View Related Stories »
- Credit Suisse | View Related Stories »
- Deutsche Bank | View Related Stories »
- Raymond James | View Related Stories »
- Morgan Stanley | View Related Stories »
- Morgan Joseph | View Related Stories »
- Hilliard Lyons | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
- 13D | View Related Stories »
- Ladenburg Thalmann Financial Services | View Related Stories »
- Susquehanna International Group of Companies | View Related Stories »
- Cantor Fitzgerald | View Related Stories »
- Piper Jaffray | View Related Stories »
- Jefferies & Co | View Related Stories »
- Banc of America | View Related Stories »
- Notable Analyst Rating Changes | View Related Stories »
- Carl Icahn | View Related Stories »
- Initial Jobless Claims | View Related Stories »
- GLG Partners | View Related Stories »
- Trading Radar | View Related Stories »
View All Major News StreetInsider.com Major News for MEND
- Micrus Endovascular (MEND) Posts Q3 EPS of $0.22, Tops Street Views
- Micrus Endovascular (MEND) Tops Q1 Views; Raises FY10 Sales Guidance
- Micrus Endovascular (MEND) Tops Q1 Results By 9c
View All ReportsStreetInsider.com Reports on MEND
- Susquehanna Maintains a 'Positive' Rating on Micrus Endovascular (MEND); Long-Term Story Remains Intact
- Morning Movers 11/05: ROYL, RX, FSYS, KAI, SANM Higher; SMSI, CVS, MBRK, INOD, PL, ARO Lower
- Micrus Endovascular (MEND) Posts Q3 EPS of $0.22, Tops Street Views
- Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
- Notable Analyst Rating Changes 9/4: CTCM, BBD, GFA, MOV Upgraded; PSO, ARRY, ANF, ZUMZ, TTWO Downgraded
View All Press ReleasesCompany Press Releases on MEND
- Micrus Endovascular to Present at the Piper Jaffray 21st Annual Health Care Conference
- Micrus Endovascular Reports Fiscal Second Quarter Revenues of $21.5 Million and Diluted EPS of $0.22
- Micrus Endovascular to Present at the Canaccord Cardiovascular Conference
- Micrus Endovascular to Hold Fiscal 2010 Second Quarter Conference Call on November 5
StreetInsider Reports on MEND by Category
View All BlogsBlogs on MEND
- Ray of Light: Nigeria's oil rebels announce 'indefinite cease fire'
- M&A Watch: 8 Medical Consumables Companies That Look Like Buyout Targets
- Micrus Endovascular Corporation F1Q09 (Qtr End 06/30/08) Earnings Call Transcript
- Micrus Endovascular Q4 2008, Earnings Call Transcript
- Royal Dutch Shell plant in Nigeria bombed -- oil supply concerns mount
View All FilingsSEC Filings on MEND
- Form 4 MICRUS ENDOVASCULAR CORP For: Nov 16 Filed by: HENSON MICHAEL R
- Form 4 MICRUS ENDOVASCULAR CORP For: Nov 13 Filed by: Robbins Jim B
- Form 10-Q MICRUS ENDOVASCULAR CORP For: Sep 30
- Form 8-K MICRUS ENDOVASCULAR CORP For: Nov 05
- Form 8-K MICRUS ENDOVASCULAR CORP For: Sep 30
Comments on MEND
No comments are currently available.
